Antibody
IgG4,k
Biosimilar
Reset all filters

Min CHF:
Max CHF:
  1-30 of 304
Supplier Product name Cat.no. Pack size Price
Pembrolizumab Biosimilar - Research Grade ICH4029-100MG ICH4029-1MG ICH4029-5MG ICH4029-10MG ICH4029-20MG ICH4029-50MG 368,00 800,00 1'241,00 2'101,00 3'933,00 Inquire
Anti-Integrin alpha 4 [Natalizumab], Human IgG4 kappa, Purified Ab00716-13.0 Ab00716-13.0-BT 550,00 2'170,00
Anti-alpha 5 beta 1 Integrin [M200 (Volociximab)], Human IgG4 kappa, Purified Ab00449-13.0 Ab00449-13.0-BT 550,00 2'170,00
Anti-TNF alpha [CDP 571 (Humicade)], Human IgG4 kappa, Purified Ab00448-13.0 Ab00448-13.0-BT 550,00 2'170,00
Nivolumab Biosimilar - Research Grade ICH4009-100MG ICH4009-1MG ICH4009-5MG ICH4009-10MG ICH4009-20MG ICH4009-50MG 168,00 575,00 885,00 1'505,00 3'158,00 Inquire
Anti-CD41 [7E3 (Abciximab)], Human IgG4 kappa, Purified Ab00282-13.0 Ab00282-13.0-BT 550,00 2'170,00
Talquetamab Biosimilar - Research Grade ICH5207-50MG ICH5207-100MG ICH5207-1MG ICH5207-5MG ICH5207-10MG ICH5207-20MG 420,00 1'298,00 2'331,00 3'390,00 Inquire Inquire
Natalizumab Biosimilar - Research Grade: Dylight®488 ICH4037D488-100uG 420,00
Tabalumab Biosimilar - Research Grade: Dylight®488 ICH5103D488-100uG 420,00
Nivolumab Biosimilar - Research Grade: Dylight®488 ICH4009D488-100uG 420,00
Tabalumab Biosimilar - Research Grade: Biotin ICH5103B-100uG 420,00
Tabalumab Biosimilar - Research Grade: HRP ICH5103HRP-100uG 420,00
Natalizumab Biosimilar - Research Grade: APC ICH4037APC-50uG 316,00
Natalizumab Biosimilar - Research Grade: PE ICH4037PE-50uG 316,00
Tabalumab Biosimilar - Research Grade: PE ICH5103PE-50uG 316,00
  1-30 of 304

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56
info@lucerna-chem.ch

Business Hours
Monday to Friday
08:00 – 12:00
13:00 – 17:00

Technical Support
tech@lucerna-chem.ch
Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

© Copyright 2021 Lucerna-Chem AG, Switzerland

Order Conditions | Privacy Policy | Terms & Conditions | Impressum